Skip to main content


29-09-2021 | EASD 2021 | Conference coverage | News

Age at type 1 diabetes diagnosis is decreasing within families

The age at diagnosis of type 1 diabetes has decreased substantially across successive generations, show study findings presented at the virtual 57th EASD Annual Meeting.

19-08-2021 | Pancreatitis | News

Postpancreatitis diabetes commonly misclassified and unsuitably treated

Postpancreatitis diabetes mellitus is under-recognized and often misclassified as type 2 diabetes, which can result in improper treatment, population-based study data show.

23-07-2021 | Children | News

Autoantibody variation at seroconversion may indicate future diabetes risk in children

Children at increased genetic risk for type 1 diabetes are more likely to develop the condition if they have multiple, rather than single, islet autoantibodies present at the time of seroconversion, a combined analysis of prospective cohorts shows.

20-04-2021 | DUKPC 2021 | Conference coverage | News

Routine autoantibody measurement advised for suspected adult type 1 diabetes

A majority of adults with clinically diagnosed type 1 diabetes but no islet autoantibodies have a low genetic risk for the condition, suggesting misdiagnosis, report researchers.

20-04-2021 | DUKPC 2021 | Conference coverage | News

Straightforward ultrasound measurement may predict gestational diabetes

Visceral adipose tissue depth measured during the first trimester of pregnancy predicts gestational diabetes better than current clinical indicators, research suggests.

10-03-2021 | Diagnosis | News

Two-step screening may be best for gestational diabetes

Single-step screening for gestational diabetes makes twice the number of diagnoses of the two-step approach without resulting in better outcomes for women and infants, shows the randomized ScreenR2GDM trial.

22-12-2020 | Diagnosis | News

Regression to mean accounts for many remissions from apparent type 2 diabetes

A large number of people diagnosed with type 2 diabetes achieve intermediate or even normal glucose levels within the following few years, with regression to the mean accounting for more than half of these remissions, research suggests.

22-09-2020 | EASD 2020 | Conference coverage | News

Screening could give 2 years’ extra type 2 diabetes treatment time

Screening of people aged 40 to 70 years using glycated hemoglobin would detect type 2 diabetes approximately 2 years earlier than when it is identified due to symptoms or incidental diagnosis, suggests an analysis of the UK Biobank.

Image Credits